Krystal Biotech (KRYS) Stock News
$KRYS · NASDAQ · HEALTHCARE · 2 stories in 30 days$318.00
1D −4.30%1W +6.67%1M +2.15%
BORSA has published 2 stories on Krystal Biotech (KRYS) in the past 30 days. BORSA’s news read on KRYS is bullish at 68/100, based on 2 company events over the past 7 days. KRYS last closed at $332.29 on Oct 30, up 6.67% over five sessions and up 2.15% over the past month. Krystal Biotech last reported quarterly results on Aug 3, 2026, for the quarter ended Jun 30, 2026.
The wire on $KRYS
newest first · updated · direct subject stories onlyKrystal Biotech Board Authorizes $400 Million Share Buyback
Krystal Biotech Board Authorizes $400 Million Share Buyback.
bullish 70 · impact 60Krystal Biotech 3Q revenue $127.3M, EPS $2.05
Krystal Biotech reported Q3 revenue of $127.3 million and EPS of $2.05.
neutral 50 · impact 40The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card